Synopsis
0
JDMF
0
EU WC
0
KDMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Digital Content
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
73
PharmaCompass offers a list of Imidacloprid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Imidacloprid manufacturer or Imidacloprid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Imidacloprid manufacturer or Imidacloprid supplier.
PharmaCompass also assists you with knowing the Imidacloprid API Price utilized in the formulation of products. Imidacloprid API Price is not always fixed or binding as the Imidacloprid Price is obtained through a variety of data sources. The Imidacloprid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A IMIDACLOPRID (CAS NO. 105827-78-9) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of IMIDACLOPRID (CAS NO. 105827-78-9), including repackagers and relabelers. The FDA regulates IMIDACLOPRID (CAS NO. 105827-78-9) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. IMIDACLOPRID (CAS NO. 105827-78-9) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of IMIDACLOPRID (CAS NO. 105827-78-9) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A IMIDACLOPRID (CAS NO. 105827-78-9) supplier is an individual or a company that provides IMIDACLOPRID (CAS NO. 105827-78-9) active pharmaceutical ingredient (API) or IMIDACLOPRID (CAS NO. 105827-78-9) finished formulations upon request. The IMIDACLOPRID (CAS NO. 105827-78-9) suppliers may include IMIDACLOPRID (CAS NO. 105827-78-9) API manufacturers, exporters, distributors and traders.
click here to find a list of IMIDACLOPRID (CAS NO. 105827-78-9) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A IMIDACLOPRID (CAS NO. 105827-78-9) DMF (Drug Master File) is a document detailing the whole manufacturing process of IMIDACLOPRID (CAS NO. 105827-78-9) active pharmaceutical ingredient (API) in detail. Different forms of IMIDACLOPRID (CAS NO. 105827-78-9) DMFs exist exist since differing nations have different regulations, such as IMIDACLOPRID (CAS NO. 105827-78-9) USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A IMIDACLOPRID (CAS NO. 105827-78-9) DMF submitted to regulatory agencies in the US is known as a USDMF. IMIDACLOPRID (CAS NO. 105827-78-9) USDMF includes data on IMIDACLOPRID (CAS NO. 105827-78-9)'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The IMIDACLOPRID (CAS NO. 105827-78-9) USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of IMIDACLOPRID (CAS NO. 105827-78-9) suppliers with USDMF on PharmaCompass.
A IMIDACLOPRID (CAS NO. 105827-78-9) CEP of the European Pharmacopoeia monograph is often referred to as a IMIDACLOPRID (CAS NO. 105827-78-9) Certificate of Suitability (COS). The purpose of a IMIDACLOPRID (CAS NO. 105827-78-9) CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of IMIDACLOPRID (CAS NO. 105827-78-9) EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of IMIDACLOPRID (CAS NO. 105827-78-9) to their clients by showing that a IMIDACLOPRID (CAS NO. 105827-78-9) CEP has been issued for it. The manufacturer submits a IMIDACLOPRID (CAS NO. 105827-78-9) CEP (COS) as part of the market authorization procedure, and it takes on the role of a IMIDACLOPRID (CAS NO. 105827-78-9) CEP holder for the record. Additionally, the data presented in the IMIDACLOPRID (CAS NO. 105827-78-9) CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the IMIDACLOPRID (CAS NO. 105827-78-9) DMF.
A IMIDACLOPRID (CAS NO. 105827-78-9) CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. IMIDACLOPRID (CAS NO. 105827-78-9) CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of IMIDACLOPRID (CAS NO. 105827-78-9) suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing IMIDACLOPRID (CAS NO. 105827-78-9) as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for IMIDACLOPRID (CAS NO. 105827-78-9) API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture IMIDACLOPRID (CAS NO. 105827-78-9) as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain IMIDACLOPRID (CAS NO. 105827-78-9) and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a IMIDACLOPRID (CAS NO. 105827-78-9) NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of IMIDACLOPRID (CAS NO. 105827-78-9) suppliers with NDC on PharmaCompass.
IMIDACLOPRID (CAS NO. 105827-78-9) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of IMIDACLOPRID (CAS NO. 105827-78-9) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right IMIDACLOPRID (CAS NO. 105827-78-9) GMP manufacturer or IMIDACLOPRID (CAS NO. 105827-78-9) GMP API supplier for your needs.
A IMIDACLOPRID (CAS NO. 105827-78-9) CoA (Certificate of Analysis) is a formal document that attests to IMIDACLOPRID (CAS NO. 105827-78-9)'s compliance with IMIDACLOPRID (CAS NO. 105827-78-9) specifications and serves as a tool for batch-level quality control.
IMIDACLOPRID (CAS NO. 105827-78-9) CoA mostly includes findings from lab analyses of a specific batch. For each IMIDACLOPRID (CAS NO. 105827-78-9) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
IMIDACLOPRID (CAS NO. 105827-78-9) may be tested according to a variety of international standards, such as European Pharmacopoeia (IMIDACLOPRID (CAS NO. 105827-78-9) EP), IMIDACLOPRID (CAS NO. 105827-78-9) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (IMIDACLOPRID (CAS NO. 105827-78-9) USP).
